Petrus J. Bekker
2016
In 2016, Petrus J. Bekker earned a total compensation of $931.5K as Chief Medical Officer at ChemoCentryx, a 45% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $143,642 |
|---|---|
| Option Awards | $233,178 |
| Salary | $410,405 |
| Stock Awards | $142,800 |
| Other | $1,462 |
| Total | $931,482 |
Bekker received $410.4K in salary, accounting for 44% of the total pay in 2016.
Bekker also received $143.6K in non-equity incentive plan, $233.2K in option awards, $142.8K in stock awards and $1.5K in other compensation.
Rankings
In 2016, Petrus J. Bekker's compensation ranked 8,580th out of 14,075 executives tracked by ExecPay. In other words, Bekker earned more than 39.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,580 out of 14,075 | 39th |
Division Manufacturing | 3,303 out of 5,489 | 40th |
Major group Chemicals And Allied Products | 1,115 out of 1,895 | 41st |
Industry group Drugs | 872 out of 1,538 | 43rd |
Industry Pharmaceutical Preparations | 692 out of 1,176 | 41st |
Source: SEC filing on April 10, 2017.
Bekker's colleagues
We found two more compensation records of executives who worked with Petrus J. Bekker at ChemoCentryx in 2016.